Showing results (21-30 of 42) with videos related to
Sort By:
Pageof 5
Journal of Thrombosis and Haemostasis : JTH|October 16, 2010
Molecular weight fibrinogen variants alter gene expression and functional characteristics of human endothelial cellsE M Weijers, M H van Wijhe, L Joosten, et al.Journal of Thrombosis and Haemostasis : JTH|August 26, 2016
Low ADAMTS-13 activity and the risk of coronary heart disease - a prospective cohort study: the Rotterdam StudyM A H Sonneveld, M Kavousi, M A Ikram, et al.Atherosclerosis|May 15, 2009
Lower levels of ADAMTS13 are associated with cardiovascular disease in young patientsT N Bongers, E L E de Bruijne, D W J Dippel, et al.Thrombosis and Haemostasis|February 4, 2010
The influence of variation in the P2Y12 receptor gene on in vitro platelet inhibition with the direct P2Y12 antagonist cangrelorH J Bouman, J W van Werkum, G Rudez, et al.Journal of Thrombosis and Haemostasis : JTH|November 21, 2007
Thrombin-activatable fibrinolysis inhibitor is associated with severity and outcome of severe meningococcal infection in childrenM Emonts, E L E de Bruijne, A H C Guimarães, et al.Journal of Thrombosis and Haemostasis : JTH|January 20, 2012
Genetic determinants of von Willebrand factor plasma levels and the risk of stroke: the Rotterdam StudyM C Van Schie, R G Wieberdink, P J Koudstaal, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|May 28, 2005
No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic miceA Trion, M P M de Maat, J W Jukema, et al.Thrombosis Research|September 16, 2011
Fibrinogen γ' levels in patients with intracerebral hemorrhageE G van den Herik, E Y L Cheung, L M L de Lau, et al.Cardiovascular Drugs and Therapy|December 17, 2008
The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery diseaseJ J Brugts, M P M de Maat, E Boersma, et al.European Cells & Materials|March 5, 2015
Full regeneration of segmental bone defects using porous titanium implants loaded with BMP-2 containing fibrin gelsJ van der Stok, M K E Koolen, M P M de Maat, et al.Pageof 5